リンパ浮腫治療の世界市場 (2023～2030年)：エンドユーザー・製品タイプ・症状タイプ・治療タイプ別の規模・シェア・成長分析・予測

リンパ浮腫治療の市場規模は、2021年に7億8653万米ドル、2022年に8億6014万米ドルを示し、2023年から2030年にかけての予測期間中は9.5%のCAGRで推移し、2030年には17億3,536万米ドル米ドルの規模に成長すると予測されています。

乳癌の発生率の上昇、リンパ浮腫の有病率の上昇、市場参入企業による複数の新製品の導入、技術進歩の結果としての効率的な製品へのニーズの上昇などがリンパ浮腫治療市場の成長を促す主な要因となっています。

当レポートでは、世界のリンパ浮腫治療の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

親市場分析

• 市場概要
• 市場規模
• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 主要な市場洞察
• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品の分析
• マクロ経済指標
• 主要投資分析
• 主要成功要因
• 競合の程度
• 市場力学と見通し
• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 規制状況
• ポーターの分析
• 将来のディスラプションに関するSkyquestの特別な洞察
• 世界のリンパ浮腫治療市場：エンドユーザー別
• 市場概要
• 病院
• 外来手術センター
• 専門クリニック
• その他
• 世界のリンパ浮腫治療市場：製品別
• 市場概要
• 圧迫包帯
• 着圧ストッキング
• 空気圧迫デバイス
• その他
• 世界のリンパ浮腫治療市場：症状タイプ別
• 市場概要
• 癌
• 心血管疾患
• 炎症性疾患
• その他
• 世界のリンパ浮腫治療市場：治療タイプ別
• 市場概要
• 圧迫療法
• 手術
• 薬物療法
• レーザー治療
• その他
• 世界のリンパ浮腫治療市場：地域別
• 市場概要
• 北米
• 米国
• カナダ
• 欧州
• ドイツ
• スペイン
• フランス
• 英国
• その他の欧州
• アジア太平洋
• 中国
• インド
• 日本
• 韓国
• その他のアジア太平洋
• ラテンアメリカ
• ブラジル
• その他のラテンアメリカ
• 中東・アフリカ
• GCC諸国
• 南アフリカ
• その他の中東・アフリカ
• 競合情勢
• 主要5社の比較
• 主要企業の位置付け
• 主要企業の採用戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア
• 主要企業プロファイル
• Bio Compression Systems
• Tactile Medical
• Medi
• Lympha Press
• Sigvaris
• BSN Medical
• L&R USA Inc.
• Devon Medical Products
• 3M Health Care
• JOBST USA
• Thuasne
• Wright Therapy Products
• BioHorizons IPH, Inc.
• Haddenham Healthcare
• ArjoHuntleigh
• Paul Hartmann
• Bioventus
• Baxter International Inc.
• CircAid Medical Products, Inc.
• Essity Aktiebolag

Lymphedema Treatment Market size was valued at USD 786.53 million in 2021 and is poised to grow from USD 860.14 million in 2022 to USD 1735.36 million by 2030, growing at a CAGR of 9.5% in the forecast period (2023-2030).

A condition known as lymphedema is characterised by abnormal swelling of the body brought on by lymphocytosis as a result of lymphatic system failure. The lower extremity is affected 90% of the time, the upper extremity 10%, and the genitalia 1%. The most common cause of lymphedema (filariasis) is an infection brought on by the parasite Wuchereria bancrofti. Lymphedema is among the most dreaded and unlucky side effects of breast cancer treatment. According to a National Centre for Biotechnology Information (NCBI) research, 40 percent of breast cancer patients experienced lymphedema. The primary factors driving the growth of the lymphedema treatment market are the rising incidence of breast cancer, the rising prevalence of lymphedema, the introduction of several new products by prominent market participants, and the rising need for efficient products as a consequence of technological advancements.

The lymph node draining condition known as lymphedema can appear in cancer patients before or after treatment, according to the US Department of Health and Human Services. For instance, it has been noted that it may occur immediately or up to 30 years after breast cancer treatment. Additionally, 80% of patients start showing symptoms 3 years after surgery, with the remaining 20% developing edoema at a rate of 1% every year. Additionally, after the treatment of gynecologic cancer, a sizeable patient population, primarily women, develops lower-limb lymphedema, with vulvar cancer survivors having the highest frequency (37%) and ovarian cancer survivors having the lowest prevalence (7%). Additionally, the incidence of arm lymphedema varied from 8% to 56% two years after surgery. According to the Alliance Z 1071 longitudinal substudy of the American College of Surgeons Oncology Group (ACOSOG), participants in breast cancer trials report a 3-year cumulative incidence of arm edoema and arm heaviness. Cutting edge and very effective cancer treatment options aid in lowering the risk of lymphedema. The major players in the market for cancer therapeutics are working very hard to introduce innovative products as a result.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lymphedema Treatment Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Based on product, the market is segmented into compression bandages, compression stockings, pneumatic compression devices, others. Based on affected area, the market is segmented into Genital, Lower Extremity, Upper Extremity and Others. Based on age group, the market is segmented into adult and geriatric. Based on route of administration, the market is segmented into Oral, Injectable and Others. Based on type, the market is segmented into primary and secondary lymphedema. Based on condition type, the market is segmented into cancer, cardiovascular diseases, inflammatory diseases, and others. Based on treatment type, the market is segmented into Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others. Based on region, the global market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

As cases of breast cancer and lymphedema rise, it is projected that the market for lymphedema treatments would expand. The likelihood of developing cancer is predicted to rise, creating tremendous opportunity for market expansion. Increasing health spending and growing investments in drug discovery research and development have increased the demand for healthcare facilities. The development of novel lymphedema treatment options is also projected to support market expansion throughout the forecasted period.

The market expansion in the upcoming years is projected to be accelerated by technological developments in lymphedema treatment methods. Additionally, the rise of the market is undoubtedly facilitated by the government's favourable programmes and the reimbursement requirements.

Restraint

Despite advances in technology, there is still no permanent treatment for lymphedema, which is anticipated to limit market growth.

The high cost of procedures and treatments is anticipated to restrict market growth.

Market Trends

As more people experience the ailment, the market for lymphedema treatments is anticipated to grow. Additionally, innovative and cutting-edge treatments are being developed at an exponential rate to lower risk throughout treatment as the disease develops further. Increasing healthcare spending is also predicted to spur industry growth and an increase in healthcare innovation. Additionally, pharmaceutical companies are encouraging worldwide business globalisation by introducing cutting-edge medical equipment.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
• Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Lymphedema Treatment Market by End-User
• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
• Global Lymphedema Treatment Market by Product
• Market Overview
• Compression Bandages
• Compression Stockings
• Pneumatic Compression Devices
• Others
• Global Lymphedema Treatment Market by Condition Type
• Market Overview
• Cancer
• Cardiovascular Diseases
• Inflammatory Diseases
• Others
• Global Lymphedema Treatment Market by Treatment Type
• Market Overview
• Compression Therapy
• Surgery
• Drug Therapy
• Laser Therapy
• Others
• Global Lymphedema Treatment Market Size by Region
• Market Overview
• North America
• USA
• Canada
• Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021
• Key Company Profiles
• Bio Compression Systems
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Tactile Medical
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Medi
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Lympha Press
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Sigvaris
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• BSN Medical
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• L&R USA Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Devon Medical Products
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• 3M Health Care
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• JOBST USA
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Thuasne
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Wright Therapy Products
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• BioHorizons IPH, Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Haddenham Healthcare
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• ArjoHuntleigh
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Paul Hartmann
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bioventus
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Baxter International Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• CircAid Medical Products, Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Essity Aktiebolag
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments